Revlimid (lenalidomide) is a brand-name oral capsule prescribed for certain types of myeloma, lymphoma, and anemia. As with other drugs, Revlimid can cause side effects, such as skin rash and ...

Margarita burn is a skin rash that occurs when lime juice reacts with sunlight and triggers skin inflammation. Dermatologist ...

The FDA warned that doctors should be on the alert for symptoms and discontinue the drug if a rash appears. According to the company, 60,000 patients have been treated with Revlimid since it was ...

Celgene Corporation (NASDAQ:CELG), today announced results from two studies (Abstracts #1143, LBA-1) evaluating the investigational use of REVLIMID® ( ...

REVLIMID interruption or discontinuation should be considered for Grade 2-3 skin rash. REVLIMID must be discontinued for angioedema, Grade 4 rash, exfoliative or bullous rash, or if SJS or TEN is ...

Bristol-Myers Squibb Company today announced that the European Commission has approved a new indication for Revlimid, in combination with rituximab, for the treatment of adult patients with ...

Bristol Myers Squibb Co on Thursday reported quarterly earnings that beat analysts' estimates due to a smaller-than-expected drop in sales of cancer drug Revlimid, which is facing competition from ...

Celgene announced results from a Phase 2 study evaluating the combination of Revlimid (lenalidomide) plus Vidaza (azacitidine) in patients ≥60 years with untreated acute myeloid leukemia (AML).

REVLIMID ® (lenalidomide) interruption or discontinuation should be considered for Grade 2-3 skin rash. REVLIMID ® (lenalidomide) must be discontinued for angioedema, Grade 4 rash, exfoliative ...

Less commonly, patients have experienced chest pain, menstrual cramps, swelling in the limbs, skin rash, and worsening of colitis. For full prescribing information, see package insert located here .

SAN FRANCISCO (CBS.MW) -- Shares of Celgene fell as much as 29 percent Wednesday after the biopharmaceutical firm said it was stopping a Phase III trial of a skin-cancer drug. Shares of the Warren ...

REVLIMID ® (lenalidomide) interruption or discontinuation should be considered for Grade 2-3 skin rash. REVLIMID ® (lenalidomide) must be discontinued for angioedema, Grade 4 rash, exfoliative ...